CORMEDIX

CRMD AMEX
8.20
-0.09
-1.11%
Opening 14:35 08/21 EDT
Open
8.32
Prev Close
8.29
High
8.39
Low
8.05
Volume
120.80K
Avg Vol (3M)
384.44K
52 Week High
13.70
52 Week Low
1.900
% Turnover
0.51%
Market Cap
195.32M
1D
5D
1M
3M
1Y
5Y

Company Profile

CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.
MORE >

Recently

Name
Price
%Change